Vellas B - Search Results

1

Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders.

Vellas B, Black R, Thal LJ, Fox NC, Daniels M, McLennan G, Tompkins C, Leibman C, Pomfret M, Grundman M; AN1792 (QS-21)-251 Study Team. Vellas B, et al. Curr Alzheimer Res. 2009 Apr;6(2):144-51. doi: 10.2174/156720509787602852. Curr Alzheimer Res. 2009. PMID: 19355849 Free PMC article. Clinical Trial.

2

Mild cognitive impairment: a nosological entity?

Voisin T, Touchon J, Vellas B. Voisin T, et al. Among authors: vellas b. Curr Opin Neurol. 2003 Dec;16 Suppl 2:S43-5. Curr Opin Neurol. 2003. PMID: 15129850 Review.

3

Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease.

Vellas B, Cunha L, Gertz HJ, De Deyn PP, Wesnes K, Hammond G, Schwalen S; GAL-INT-28 Study Group. Vellas B, et al. Curr Med Res Opin. 2005 Sep;21(9):1423-9. doi: 10.1185/030079905X61884. Curr Med Res Opin. 2005. PMID: 16197661

4

[Treatment of Alzheimer's disease].

Bombois S, Lebert F, Vellas B, Pasquier F. Bombois S, et al. Among authors: vellas b. Rev Prat. 2005 Nov 15;55(17):1913-9. Rev Prat. 2005. PMID: 16396232 Review. French.

5

Family history of dementia does not influence the progression of Alzheimer's disease at two years: results from the REAL.FR Study.

Cortes F, Gillette-Guyonnet S, Nourhashemi F, Christelle C, Vellas B. Cortes F, et al. Among authors: vellas b. Am J Alzheimers Dis Other Demen. 2006 Mar-Apr;21(2):131-6. doi: 10.1177/153331750602100214. Am J Alzheimers Dis Other Demen. 2006. PMID: 16634470 Free PMC article.

6

Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.

Helmer C, Andrieu S, Pérès K, Orgogozo JM, Vellas B, Dartigues JF; REAL.fr Group. Helmer C, et al. Among authors: vellas b. Dement Geriatr Cogn Disord. 2007;23(3):168-74. doi: 10.1159/000098516. Epub 2007 Jan 11. Dement Geriatr Cogn Disord. 2007. PMID: 17215578

7

A 2-year follow-up of 233 very mild (CDR 0.5) Alzheimer's disease patients (REAL.FR cohort).

Nourhashémi F, Ousset PJ, Gillette-Guyonnet S, Cantet C, Andrieu S, Vellas B; REAL.FR cohort. Nourhashémi F, et al. Among authors: vellas b. Int J Geriatr Psychiatry. 2008 May;23(5):460-5. doi: 10.1002/gps.1904. Int J Geriatr Psychiatry. 2008. PMID: 17894422

8

Alzhemed: a potential treatment for Alzheimer's disease.

Aisen PS, Gauthier S, Vellas B, Briand R, Saumier D, Laurin J, Garceau D. Aisen PS, et al. Among authors: vellas b. Curr Alzheimer Res. 2007 Sep;4(4):473-8. doi: 10.2174/156720507781788882. Curr Alzheimer Res. 2007. PMID: 17908052 Review.

9

Nutritional status is associated with disease progression in very mild Alzheimer disease.

Ousset PJ, Nourhashemi F, Reynish E, Vellas B. Ousset PJ, et al. Among authors: vellas b. Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):66-71. doi: 10.1097/WAD.0b013e31815a9dbb. Alzheimer Dis Assoc Disord. 2008. PMID: 18317249

10

Endpoints for trials in Alzheimer's disease: a European task force consensus.

Vellas B, Andrieu S, Sampaio C, Coley N, Wilcock G; European Task Force Group. Vellas B, et al. Lancet Neurol. 2008 May;7(5):436-50. doi: 10.1016/S1474-4422(08)70087-5. Lancet Neurol. 2008. PMID: 18420157 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,134 results

Search Page

Filters